HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
HESI PHARMACOLOGY NIGHTINGALE COLLEGE
FALL 2026/2027 (NIGHTINGALE BSN 315 COURSE)
QUESTIONS WITH COMPLETE SOLUTIONS
Course: Nightingale College BSN 315 | HESI Specialty Pharmacology Examination Preparation
Edition: Fall 2026/2027 | Total: 150 Questions with Complete Solutions
Aligned with the Nightingale College BSN 315 HESI Specialty Pharmacology Exam Blueprint, NCLEX-RN
Pharmacology Standards, and Evidence-Based Nursing Competencies
Cognitive Levels: 20% Recall | 50% Application | 30% Analysis (includes NGN-style cases, dosage calculations, and
clinical reasoning)
Section 1: Pharmacokinetics & Pharmacodynamics
Q1. A nursing student is reviewing the four processes of pharmacokinetics with a clinical instructor at
Nightingale College. Which action is correctly identified as occurring during the distribution phase of
pharmacokinetics?
A. Binding of a drug to plasma proteins such as albumin *[CORRECT]*
B. Conversion of a drug to inactive metabolites by hepatic enzymes
C. Movement of a drug from the gastrointestinal tract into the bloodstream
D. Filtration of free drug from the glomerulus into the renal tubule
Correct Answer: A
Rationale: Distribution is the transport of drug molecules to tissues and organs via the bloodstream, where reversible
binding to plasma proteins such as albumin occurs; only the unbound (free) fraction is pharmacologically active.
Conversion by hepatic enzymes describes metabolism, absorption describes entry into the bloodstream, and
glomerular filtration describes excretion. Per the Nightingale College BSN 315 pharmacology framework, ADME
processes must be distinguished precisely on NCLEX-RN style items.
Q2. Which route of medication administration provides a drug with essentially 100% bioavailability because it
bypasses all absorption barriers?
A. Oral (PO) route
B. Intravenous (IV) route *[CORRECT]*
C. Subcutaneous (SubQ) route
D. Rectal (PR) route
Correct Answer: B
Rationale: Intravenous administration places the drug directly into the systemic circulation, so no absorption step
occurs and bioavailability is complete (100%). Oral, subcutaneous, and rectal routes are all subject to incomplete or
variable absorption, and the oral route is additionally reduced by hepatic first-pass metabolism. Nightingale College
BSN 315 curriculum identifies IV dosing as the reference standard when teaching bioavailability calculations.
1
,HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
Q3. A nurse is preparing to administer sublingual nitroglycerin to a client experiencing acute anginal chest
pain. The client asks why the tablet must be placed under the tongue instead of swallowed. Which explanation
is accurate?
A. Sublingual administration bypasses hepatic first-pass metabolism, allowing rapid absorption into
systemic circulation *[CORRECT]*
B. Sublingual administration prevents the drug from entering the systemic circulation
C. Swallowed nitroglycerin is completely destroyed by gastric hydrochloric acid
D. Sublingual administration slows absorption to prevent hypotension
Correct Answer: A
Rationale: Nitroglycerin undergoes extensive first-pass metabolism when swallowed, inactivating most of the dose;
sublingual absorption enters the systemic circulation directly through the rich capillary bed under the tongue.
Nitroglycerin is not destroyed by gastric acid; rather, hepatic biotransformation is the problem with the oral route.
The BSN 315 HESI blueprint highlights first-pass effect as a highly tested pharmacokinetic concept, and sublingual
nitroglycerin is the prototype example.
Q4. A client stabilized on atorvastatin 40 mg daily drinks two large glasses of grapefruit juice every morning.
Which mechanism best explains why the nurse should teach this client to avoid grapefruit juice?
A. Grapefruit juice induces CYP3A4, accelerating statin metabolism and lowering drug levels
B. Grapefruit juice inhibits intestinal CYP3A4, increasing atorvastatin absorption and serum levels
with a risk of myopathy and rhabdomyolysis *[CORRECT]*
C. Grapefruit juice binds atorvastatin in the gut, forming an insoluble chelation complex
D. Grapefruit juice alkalinizes the urine, decreasing renal excretion of atorvastatin
Correct Answer: B
Rationale: Components of grapefruit juice irreversibly inhibit CYP3A4 in the intestinal wall, so more parent statin
reaches the bloodstream and plasma concentrations rise, increasing the risk of myopathy and rhabdomyolysis.
Inhibition, not induction, is the mechanism, and chelation interactions are characteristic of dairy or cation-binding
agents with drugs such as tetracycline. Nightingale College BSN 315 curriculum lists the grapefruit juice-statin
interaction as the prototype CYP3A4 inhibition interaction for the HESI Specialty Pharmacology Exam.
Q5. A client receiving warfarin, which is approximately 99% protein bound, is newly prescribed a second
medication that is also highly protein bound. The nurse recognizes that the primary risk of this drug-drug
interaction is which of the following?
A. Decreased free warfarin levels causing subtherapeutic anticoagulation
B. Displacement of warfarin from plasma proteins, increasing the free fraction and raising the risk of
bleeding *[CORRECT]*
C. Enhanced hepatic metabolism of warfarin, lowering INR values
D. Increased protein-bound fraction, strengthening the anticoagulant effect
Correct Answer: B
Rationale: When two highly protein-bound drugs compete for albumin binding sites, the second drug displaces
warfarin, sharply increasing the free (active) fraction of warfarin and producing a dangerous anticoagulant effect
with bleeding risk. The INR should be monitored closely when any highly bound drug is added. This displacement
interaction concept is emphasized in the Nightingale College BSN 315 protein-binding and drug-interaction
objectives.
2
,HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
Q6. A medication has a half-life of 6 hours. The nurse teaches a student nurse that, with repeated fixed dosing,
the drug will reach steady-state plasma concentration in approximately how long?
A. 12 to 18 hours
B. 24 to 30 hours *[CORRECT]*
C. 36 to 42 hours
D. 48 to 54 hours
Correct Answer: B
Rationale: Steady state is achieved after about 4 to 5 half-lives of consistent dosing; with a 6-hour half-life, that
equals 24 to 30 hours, at which point the rate of administration equals the rate of elimination. Options of 12 to 18
hours represent only 2 to 3 half-lives, which is insufficient. Nightingale College BSN 315 pharmacology standards
expect students to apply half-life mathematics to realistic dosing scenarios on the HESI Specialty Pharmacology
Exam.
Q7. Which medication listed below has a narrow therapeutic index and therefore requires routine therapeutic
drug monitoring with serum laboratory levels?
A. Amoxicillin
B. Digoxin *[CORRECT]*
C. Lisinopril
D. Metformin
Correct Answer: B
Rationale: Digoxin has a narrow therapeutic index with a therapeutic range of approximately 0.5 to 2.0 ng/mL;
concentrations only slightly above this range produce serious dysrhythmias and toxicity, so serum levels are
monitored routinely. Amoxicillin, lisinopril, and metformin have wide safety margins and do not require serum level
monitoring. Narrow therapeutic index drugs such as digoxin, phenytoin, theophylline, lithium, and warfarin are a
core monitoring content item in the Nightingale College BSN 315 HESI blueprint.
Q8. The nurse is explaining why only certain medications reach the cerebrospinal fluid and brain tissue. Which
property most accurately predicts a drug's ability to cross the blood-brain barrier?
A. High degree of ionization and water solubility
B. High lipid solubility allowing passage through the blood-brain barrier *[CORRECT]*
C. Extensive binding to plasma albumin in the cerebral vasculature
D. Large molecular weight with strong polar charge
Correct Answer: B
Rationale: The blood-brain barrier consists of tight junctions that permit passage primarily of lipid-soluble, small,
un-ionized molecules, while ionized, water-soluble, and large molecules are excluded. This is why some
chemotherapeutic and antimicrobial agents fail to treat CNS infections unless specially formulated. The Nightingale
College BSN 315 distribution objectives include barrier passage as an applied pharmacokinetic concept.
3
, HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
Q9. A client who takes phenytoin for a seizure disorder has taken oral contraceptive pills for 2 years and now
presents with an unplanned pregnancy. Which pharmacokinetic mechanism best explains the contraceptive
failure?
A. Phenytoin induces hepatic CYP450 enzymes, accelerating estrogen metabolism and reducing
contraceptive effectiveness *[CORRECT]*
B. Phenytoin inhibits intestinal CYP3A4, increasing estrogen levels and causing contraceptive failure
C. Phenytoin competes for the same receptor sites as the contraceptive hormones
D. Phenytoin increases renal filtration of the contraceptive hormones
Correct Answer: A
Rationale: Phenytoin is a classic CYP450 enzyme inducer; by increasing hepatic metabolism of estrogen and
progestin, it lowers contraceptive hormone levels and leads to contraceptive failure, which is why backup or
alternative contraception is recommended. Induction increases metabolism, whereas inhibition would raise levels,
and receptor competition is not the mechanism here. Nightingale College BSN 315 curriculum presents phenytoin,
rifampin, and phenobarbital as prototype enzyme inducers tested on the HESI Specialty Pharmacology Exam.
Q10. A client stabilized on simvastatin is newly started on clarithromycin for a respiratory infection. Three
days later the client reports severe muscle pain and dark urine. Which pharmacokinetic mechanism explains
this presentation?
A. Clarithromycin induces CYP3A4, increasing statin metabolism and causing rhabdomyolysis
B. Clarithromycin inhibits CYP3A4-mediated statin metabolism, elevating simvastatin levels and
increasing the risk of myopathy and rhabdomyolysis *[CORRECT]*
C. Clarithromycin displaces simvastatin from plasma proteins, lowering active drug levels
D. Clarithromycin blocks renal tubular secretion of simvastatin
Correct Answer: B
Rationale: Clarithromycin is a potent CYP3A4 inhibitor; concurrent use with simvastatin markedly elevates statin
concentrations, producing muscle injury with myalgia and dark urine consistent with rhabdomyolysis, which requires
immediate provider notification. Induction would lower statin levels, and displacement or renal mechanisms are not
responsible for this interaction. The BSN 315 HESI blueprint tests recognition of CYP450 inhibition interactions
using the macrolide-statin pair as a prototype.
Q11. A client with a severe infection has a calculated creatinine clearance of 25 mL/min. The client is
prescribed an aminoglycoside that is primarily eliminated by the kidneys. Which adjustment should the nurse
anticipate?
A. A decreased dose or prolonged dosing interval to prevent drug accumulation *[CORRECT]*
B. An increased dose to overcome decreased glomerular filtration
C. No change in dosing because antibiotics are unaffected by renal function
D. Switching the client to the oral route of the same drug
Correct Answer: A
Rationale: Because aminoglycosides such as gentamicin are excreted almost entirely by glomerular filtration, a
creatinine clearance of 25 mL/min indicates markedly reduced excretion, so the dose must be lowered or the interval
extended to prevent toxic accumulation. Increasing the dose would worsen accumulation and raise the risk of
nephrotoxicity and ototoxicity. Dose adjustment based on renal function is a core dosage-reasoning standard in the
Nightingale College BSN 315 curriculum.
4
HESI PHARMACOLOGY NIGHTINGALE COLLEGE
FALL 2026/2027 (NIGHTINGALE BSN 315 COURSE)
QUESTIONS WITH COMPLETE SOLUTIONS
Course: Nightingale College BSN 315 | HESI Specialty Pharmacology Examination Preparation
Edition: Fall 2026/2027 | Total: 150 Questions with Complete Solutions
Aligned with the Nightingale College BSN 315 HESI Specialty Pharmacology Exam Blueprint, NCLEX-RN
Pharmacology Standards, and Evidence-Based Nursing Competencies
Cognitive Levels: 20% Recall | 50% Application | 30% Analysis (includes NGN-style cases, dosage calculations, and
clinical reasoning)
Section 1: Pharmacokinetics & Pharmacodynamics
Q1. A nursing student is reviewing the four processes of pharmacokinetics with a clinical instructor at
Nightingale College. Which action is correctly identified as occurring during the distribution phase of
pharmacokinetics?
A. Binding of a drug to plasma proteins such as albumin *[CORRECT]*
B. Conversion of a drug to inactive metabolites by hepatic enzymes
C. Movement of a drug from the gastrointestinal tract into the bloodstream
D. Filtration of free drug from the glomerulus into the renal tubule
Correct Answer: A
Rationale: Distribution is the transport of drug molecules to tissues and organs via the bloodstream, where reversible
binding to plasma proteins such as albumin occurs; only the unbound (free) fraction is pharmacologically active.
Conversion by hepatic enzymes describes metabolism, absorption describes entry into the bloodstream, and
glomerular filtration describes excretion. Per the Nightingale College BSN 315 pharmacology framework, ADME
processes must be distinguished precisely on NCLEX-RN style items.
Q2. Which route of medication administration provides a drug with essentially 100% bioavailability because it
bypasses all absorption barriers?
A. Oral (PO) route
B. Intravenous (IV) route *[CORRECT]*
C. Subcutaneous (SubQ) route
D. Rectal (PR) route
Correct Answer: B
Rationale: Intravenous administration places the drug directly into the systemic circulation, so no absorption step
occurs and bioavailability is complete (100%). Oral, subcutaneous, and rectal routes are all subject to incomplete or
variable absorption, and the oral route is additionally reduced by hepatic first-pass metabolism. Nightingale College
BSN 315 curriculum identifies IV dosing as the reference standard when teaching bioavailability calculations.
1
,HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
Q3. A nurse is preparing to administer sublingual nitroglycerin to a client experiencing acute anginal chest
pain. The client asks why the tablet must be placed under the tongue instead of swallowed. Which explanation
is accurate?
A. Sublingual administration bypasses hepatic first-pass metabolism, allowing rapid absorption into
systemic circulation *[CORRECT]*
B. Sublingual administration prevents the drug from entering the systemic circulation
C. Swallowed nitroglycerin is completely destroyed by gastric hydrochloric acid
D. Sublingual administration slows absorption to prevent hypotension
Correct Answer: A
Rationale: Nitroglycerin undergoes extensive first-pass metabolism when swallowed, inactivating most of the dose;
sublingual absorption enters the systemic circulation directly through the rich capillary bed under the tongue.
Nitroglycerin is not destroyed by gastric acid; rather, hepatic biotransformation is the problem with the oral route.
The BSN 315 HESI blueprint highlights first-pass effect as a highly tested pharmacokinetic concept, and sublingual
nitroglycerin is the prototype example.
Q4. A client stabilized on atorvastatin 40 mg daily drinks two large glasses of grapefruit juice every morning.
Which mechanism best explains why the nurse should teach this client to avoid grapefruit juice?
A. Grapefruit juice induces CYP3A4, accelerating statin metabolism and lowering drug levels
B. Grapefruit juice inhibits intestinal CYP3A4, increasing atorvastatin absorption and serum levels
with a risk of myopathy and rhabdomyolysis *[CORRECT]*
C. Grapefruit juice binds atorvastatin in the gut, forming an insoluble chelation complex
D. Grapefruit juice alkalinizes the urine, decreasing renal excretion of atorvastatin
Correct Answer: B
Rationale: Components of grapefruit juice irreversibly inhibit CYP3A4 in the intestinal wall, so more parent statin
reaches the bloodstream and plasma concentrations rise, increasing the risk of myopathy and rhabdomyolysis.
Inhibition, not induction, is the mechanism, and chelation interactions are characteristic of dairy or cation-binding
agents with drugs such as tetracycline. Nightingale College BSN 315 curriculum lists the grapefruit juice-statin
interaction as the prototype CYP3A4 inhibition interaction for the HESI Specialty Pharmacology Exam.
Q5. A client receiving warfarin, which is approximately 99% protein bound, is newly prescribed a second
medication that is also highly protein bound. The nurse recognizes that the primary risk of this drug-drug
interaction is which of the following?
A. Decreased free warfarin levels causing subtherapeutic anticoagulation
B. Displacement of warfarin from plasma proteins, increasing the free fraction and raising the risk of
bleeding *[CORRECT]*
C. Enhanced hepatic metabolism of warfarin, lowering INR values
D. Increased protein-bound fraction, strengthening the anticoagulant effect
Correct Answer: B
Rationale: When two highly protein-bound drugs compete for albumin binding sites, the second drug displaces
warfarin, sharply increasing the free (active) fraction of warfarin and producing a dangerous anticoagulant effect
with bleeding risk. The INR should be monitored closely when any highly bound drug is added. This displacement
interaction concept is emphasized in the Nightingale College BSN 315 protein-binding and drug-interaction
objectives.
2
,HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
Q6. A medication has a half-life of 6 hours. The nurse teaches a student nurse that, with repeated fixed dosing,
the drug will reach steady-state plasma concentration in approximately how long?
A. 12 to 18 hours
B. 24 to 30 hours *[CORRECT]*
C. 36 to 42 hours
D. 48 to 54 hours
Correct Answer: B
Rationale: Steady state is achieved after about 4 to 5 half-lives of consistent dosing; with a 6-hour half-life, that
equals 24 to 30 hours, at which point the rate of administration equals the rate of elimination. Options of 12 to 18
hours represent only 2 to 3 half-lives, which is insufficient. Nightingale College BSN 315 pharmacology standards
expect students to apply half-life mathematics to realistic dosing scenarios on the HESI Specialty Pharmacology
Exam.
Q7. Which medication listed below has a narrow therapeutic index and therefore requires routine therapeutic
drug monitoring with serum laboratory levels?
A. Amoxicillin
B. Digoxin *[CORRECT]*
C. Lisinopril
D. Metformin
Correct Answer: B
Rationale: Digoxin has a narrow therapeutic index with a therapeutic range of approximately 0.5 to 2.0 ng/mL;
concentrations only slightly above this range produce serious dysrhythmias and toxicity, so serum levels are
monitored routinely. Amoxicillin, lisinopril, and metformin have wide safety margins and do not require serum level
monitoring. Narrow therapeutic index drugs such as digoxin, phenytoin, theophylline, lithium, and warfarin are a
core monitoring content item in the Nightingale College BSN 315 HESI blueprint.
Q8. The nurse is explaining why only certain medications reach the cerebrospinal fluid and brain tissue. Which
property most accurately predicts a drug's ability to cross the blood-brain barrier?
A. High degree of ionization and water solubility
B. High lipid solubility allowing passage through the blood-brain barrier *[CORRECT]*
C. Extensive binding to plasma albumin in the cerebral vasculature
D. Large molecular weight with strong polar charge
Correct Answer: B
Rationale: The blood-brain barrier consists of tight junctions that permit passage primarily of lipid-soluble, small,
un-ionized molecules, while ionized, water-soluble, and large molecules are excluded. This is why some
chemotherapeutic and antimicrobial agents fail to treat CNS infections unless specially formulated. The Nightingale
College BSN 315 distribution objectives include barrier passage as an applied pharmacokinetic concept.
3
, HESI Pharmacology | Nightingale College BSN 315 | Fall 2026/2027 Edition
Q9. A client who takes phenytoin for a seizure disorder has taken oral contraceptive pills for 2 years and now
presents with an unplanned pregnancy. Which pharmacokinetic mechanism best explains the contraceptive
failure?
A. Phenytoin induces hepatic CYP450 enzymes, accelerating estrogen metabolism and reducing
contraceptive effectiveness *[CORRECT]*
B. Phenytoin inhibits intestinal CYP3A4, increasing estrogen levels and causing contraceptive failure
C. Phenytoin competes for the same receptor sites as the contraceptive hormones
D. Phenytoin increases renal filtration of the contraceptive hormones
Correct Answer: A
Rationale: Phenytoin is a classic CYP450 enzyme inducer; by increasing hepatic metabolism of estrogen and
progestin, it lowers contraceptive hormone levels and leads to contraceptive failure, which is why backup or
alternative contraception is recommended. Induction increases metabolism, whereas inhibition would raise levels,
and receptor competition is not the mechanism here. Nightingale College BSN 315 curriculum presents phenytoin,
rifampin, and phenobarbital as prototype enzyme inducers tested on the HESI Specialty Pharmacology Exam.
Q10. A client stabilized on simvastatin is newly started on clarithromycin for a respiratory infection. Three
days later the client reports severe muscle pain and dark urine. Which pharmacokinetic mechanism explains
this presentation?
A. Clarithromycin induces CYP3A4, increasing statin metabolism and causing rhabdomyolysis
B. Clarithromycin inhibits CYP3A4-mediated statin metabolism, elevating simvastatin levels and
increasing the risk of myopathy and rhabdomyolysis *[CORRECT]*
C. Clarithromycin displaces simvastatin from plasma proteins, lowering active drug levels
D. Clarithromycin blocks renal tubular secretion of simvastatin
Correct Answer: B
Rationale: Clarithromycin is a potent CYP3A4 inhibitor; concurrent use with simvastatin markedly elevates statin
concentrations, producing muscle injury with myalgia and dark urine consistent with rhabdomyolysis, which requires
immediate provider notification. Induction would lower statin levels, and displacement or renal mechanisms are not
responsible for this interaction. The BSN 315 HESI blueprint tests recognition of CYP450 inhibition interactions
using the macrolide-statin pair as a prototype.
Q11. A client with a severe infection has a calculated creatinine clearance of 25 mL/min. The client is
prescribed an aminoglycoside that is primarily eliminated by the kidneys. Which adjustment should the nurse
anticipate?
A. A decreased dose or prolonged dosing interval to prevent drug accumulation *[CORRECT]*
B. An increased dose to overcome decreased glomerular filtration
C. No change in dosing because antibiotics are unaffected by renal function
D. Switching the client to the oral route of the same drug
Correct Answer: A
Rationale: Because aminoglycosides such as gentamicin are excreted almost entirely by glomerular filtration, a
creatinine clearance of 25 mL/min indicates markedly reduced excretion, so the dose must be lowered or the interval
extended to prevent toxic accumulation. Increasing the dose would worsen accumulation and raise the risk of
nephrotoxicity and ototoxicity. Dose adjustment based on renal function is a core dosage-reasoning standard in the
Nightingale College BSN 315 curriculum.
4
